Tech Life Virgin Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Life Virgin Islands.

Press releases published on October 19, 2026

18 hours ago

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

Indeterminate GlobeNewswire

18 hours ago

Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting

Indeterminate GlobeNewswire

18 hours ago

Zone Frontier Inc. Announces 1-for-60 Reverse Stock Split

Indeterminate GlobeNewswire

18 hours ago

Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra™ in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire

18 hours ago

Data I/O Signs Definitive Agreement to Acquire V-TEK and A&J Programming

Indeterminate GlobeNewswire

18 hours ago

MKS Inc. to Sell Its Ophir® Optics Business to TTM Technologies, Inc.

Indeterminate GlobeNewswire

18 hours ago

Envoy Drives East Coast Expansion Forward with $8.1 Million Grant-Funded New Jersey Initiative

Indeterminate GlobeNewswire

18 hours ago

QTREX Regains Compliance with Nasdaq Minimum Bid Price Requirement

Indeterminate GlobeNewswire

18 hours ago

argenx to Present Phase 3 ALKIVIA Results in Autoimmune Myositis as a Late-Breaking Oral Presentation at ACR Convergence 2026

Indeterminate GlobeNewswire

18 hours ago

Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS

Indeterminate GlobeNewswire

18 hours ago

Core Molding Technologies Announces Timing of Its Fiscal 2026 Third Quarter Results

Indeterminate GlobeNewswire

18 hours ago

SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System

Indeterminate GlobeNewswire

18 hours ago

UroGen Announces FDA Acceptance of the New Drug Application for UGN-103, an Investigational Treatment for Adults with Recurrent LG-IR-NMIBC

Indeterminate GlobeNewswire

18 hours ago

Calidi Biotherapeutics to Present New CLD-401 Data and In Situ TCE Platform Advances at the ESMO Congress 2026

Indeterminate GlobeNewswire

18 hours ago

Vaxart Appoints Retired Vice Admiral Raquel C. Bono, M.D., to Board of Directors

Indeterminate GlobeNewswire

18 hours ago

Phathom Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide Business Update on Thursday, October 29, 2026

Indeterminate GlobeNewswire

18 hours ago

Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences

Indeterminate GlobeNewswire

18 hours ago

ORIC® Pharmaceuticals to Host Conference Call & Webcast to Review Enozertinib Data Being Presented at ESMO Congress 2026

Indeterminate GlobeNewswire

18 hours ago

Syncromune to Present Updated Long-Term Overall Survival Data from Phase 1 Trial of SYNC-T Therapy SV-102 in Metastatic Prostate Cancer at ESMO Congress 2026

Indeterminate GlobeNewswire

18 hours ago

Rivus Pharmaceuticals to Present Preclinical Obesity Data for Muscle-Preserving, Oral GLP-1 RV-8451 at ObesityWeek®

Indeterminate GlobeNewswire